OS Therapies (OSTX) Proxy filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for September 9, 2026, to be held virtually at 10:00 a.m. Eastern Time.

• Proxy materials, including the proxy statement and annual report, are available online for review prior to voting.

Voting matters and shareholder proposals

• Election of six directors to serve until the 2027 annual meeting and until successors are elected and qualified.

• Approval of the amendment and restatement of the 2023 Incentive Compensation Plan.

• Ratification of MaloneBailey, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Other business may be transacted, including motions to adjourn for further proxy solicitation if necessary.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and all listed proposals.